The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Angiostatin-converting Enzyme Activities of Human Matrilysin (MMP-7) and Gelatinase B/Type IV Collagenase (MMP-9)
Open accessAbstract
Angiostatin is one of the most potent inhibitors of angiogenesis. Reports have shown that metalloelastase, pancreas elastase, plasmin reductase, and plasmin convert plasminogen to angiostatin. However, the cleavage sites of plasminogen by those enzymes have not been determined. Here we demonstrate that two members of the human matrix metalloproteinase (MMP) family, matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9), hydrolyze human plasminogen to generate angiostatin fragments. The cleavage sites have been determined. The 58-kDa bands derived from plasminogen by MMP-7 and MMP-9 both have the N-terminal sequence KVYLSEXKTG, which corresponds to that of angiostatin. This N terminus is identical to that of the starting plasminogen itself and corresponds to residues 97-106 of prepro-plasminogen. The 42- and 38-kDa bands generated by MMP-7 both have the N-terminal sequence VVLLPNVETP, which corresponds to the amino acid sequence 467-476 of prepro-plasminogen, between kringle domain 4 and 5. MMP-9 cleaves plasminogen to generate a 42-kDa fragment with the N-terminal sequence PVVLLPNVE, 1 residue upstream of the MMP-7 cleavage site. These results indicate that MMP-7 and MMP-9 may regulate new blood vessel formation by cleaving plasminogen and generating angiostatin molecules.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Risau, W. (1997) · Nature · doi:10.1038/386671a0 · Cited by 5,727
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
O'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345
Merril, C. R., Goldman, D., Sedman, S. A., & Ebert, M. H. (1981) · Science · doi:10.1126/science.6162199 · Cited by 2,933
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
Liotta, L. A., Steeg, P. S., & Stetler-Stevenson, W. G. (1991) · Cell · doi:10.1016/0092-8674(91)90642-c · Cited by 2,720
Folkman, J., & Shing, Y. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49853-0 · Cited by 2,654
The implications of angiogenesis for the biology and therapy of cancer metastasis
Fidler, I. (1994) · Cell · doi:10.1016/0092-8674(94)90187-2 · Cited by 1,098
Dong, Z., Kumar, R., Yang, X., & Fidler, I. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81926-1 · Cited by 525
Goss, K. H., Matrisian, L. M., Jensen, R. A., & Rodgers, W. H. (1996) · Europe PMC (PubMed Central) · Cited by 504
Kringle Domains of Human Angiostatin
Cao, Y., Ji, R. W., Davidson, D., Schaller, J., Marti, D., Söhndel, S., McCance, S. G., O'Reilly, M. S., Llinás, M., & Folkman, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29461 · Cited by 368
The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin
Gately, S., Twardowski, P., Stack, M. S., Cundiff, D. L., Grella, D., Castellino, F. J., Enghild, J., Kwaan, H. C., Lee, F., Kramer, R. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10868 · Cited by 292
New perspectives in clinical oncology from angiogenesis research
Folkman, J. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00423-6 · Cited by 250
Overall, C. M., & Sodek, J. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)45338-5 · Cited by 234
Molecular cloning and characterization of a full‐length cDNA clone for human plasminogen
Forsgren, M., Råden, B., Israelsson, M., Larsson, K., & Hedén, L.-O. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)81501-6 · Cited by 229
Characterization of the gene for human plasminogen, a key proenzyme in the fibrinolytic system.
Petersen, T. E., Martzen, M. R., Ichinose, A., & Davie, E. W. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39298-1 · Cited by 223
Gately, S. T., Twardowski, P., Stack, M. S., Patrick, M., Boggio, L. N., Cundiff, D. L., Schnaper, H. W., Madison, L. D., Volpert, O. V., Bouck, N., et al. (1996) · PubMed · Cited by 197
Generation of Angiostatin by Reduction and Proteolysis of Plasmin
Stathakis, P., Fitzgerald, M., Matthias, L. J., Chesterman, C. N., & Hogg, P. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20641 · Cited by 163
Busiek, D. F., Ross, F. P., McDonnell, S., Murphy, G., Matrisian, L. M., & Welgus, H. G. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50392-1 · Cited by 118
Overview on fibrinolysis: Plasminogen activation pathways on fibrin and cell surfaces
Anglés‐Cano, E. (1994) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(94)90157-0 · Cited by 94
Suppression of Tumor Growth with Recombinant Murine Angiostatin
Wu, Z., O’Reilly, M. S., Folkman, J., & Shing, Y. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7032 · Cited by 92
Matrix metalloproteinases and endometrial remodelling.
Salamonsen, L. A. (1994) · Cell Biology International · doi:10.1006/cbir.1994.1040 · Cited by 50
Sang, Q. A., Bodden, M., & Windsor, L. J. (1996) · Journal of Protein Chemistry · doi:10.1007/bf01887112 · Cited by 49
Self-citation
Cited by
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kessenbrock, K., Plaks, V., & Werb, Z. (2010) · Cell · doi:10.1016/j.cell.2010.03.015 · Cited by 5,151
“The degradation of plasminogen by MMP-2, -9, and -12 can produce significant amounts of angiostatin, a cleavage product with antiangiogenic function (Cornelius et al., 1998; Patterson and Sang, 1997).”
BackgroundVisse, R., & Nagase, H. (2003) · Circulation Research · doi:10.1161/01.res.0000070112.80711.3d · Cited by 4,575
How Matrix Metalloproteinases Regulate Cell Behavior
Sternlicht, M. D., & Werb, Z. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.463 · Cited by 3,959
Bingle, L., Brown, N. J., & Lewis, C. E. (2002) · The Journal of Pathology · doi:10.1002/path.1027 · Cited by 2,022
Regulation of matrix metalloproteinase expression in tumor invasion
Westermarck, J., & Kähäri, V. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.8.781 · Cited by 1,494
Metadata
- Authors
- Patterson, B. C., & Sang, Q. A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1997-11
- Volume
- 272
- Issue
- 46
- Pages
- 28823-28825
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2022718682
- Cited by
- 433
- References
- 23
- FWCI
- 9.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.